Graph AI Raises $13.3 Million to Expand AI-Based Pharmacovigilance Platform
Graph AI, an artificial intelligence startup specializing in pharmacovigilance, raised $13.3 million in a Series A funding round led by Insight Partners with participation from Bessemer Venture Partners. The company plans to use the funds to expand its AI-native safety platform across the US and Europe. Graph AI's platform, designed for regulated environments, has significantly reduced case processing times and operating costs. It offers modules for adverse-event intake, case processing, and automated reporting, serving pharmaceutical and biotech clients globally.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (62/100). Lens Score 36/100.
Outlets measured: economictimes, businessstandard. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (50–75/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
businessstandard broke this story on 10 Sept, 03:29 pm. Other outlets followed.